Llwytho...
Red Blood Cell Product Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation
BACKGROUND: The risk of transfusion reactions (TR) and the cost of blood has led to efforts to reduce blood use. We changed our practice to transfuse just 1 instead of 2 units of red blood cells (RBC) when hemoglobin ≤8g/dl due to patient blood management (PBM) recommendations. METHODS AND MATERIALS...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Transfusion |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713712/ https://ncbi.nlm.nih.gov/pubmed/30957250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15285 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|